Article

A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individuals

2022-11-22

Abstract excerpt

<h4>Background: </h4> SARS-CoV-2 is a coronavirus that has rapidly spread across the world with a detrimental effect on the global population. Several reports have highlighted an increased mortality rate and a higher severity of COVID-19 infection in chronic kidney disease (CKD) individuals. Upon the development of various SARS-CoV-2 vaccines, mRNA vaccines including BNT162b2 and mRNA-1273 were deemed safe, with a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8d09853d-e602-5866-b0e0-02bfb35c7042
DOI: 10.12688/f1000research.122820.2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individualsDOI 10.12688/f1000research.122820.2Read

Alternative Strategies to Increase the Immunogenicity of Covid-19 Vaccines in Kidney Transplant Recipients Not Responding to Two or Three Doses of an mRNA Vaccine. A Randomized Clinical TrialSemantic proximity Read

A Malaysian Study on COVID-19 (SARS-CoV-2) Vaccination Immune Response in Haemodialysis patients: A prospective, multicenter, cohort studySemantic proximity Read

Antibody and T-Cell Responses 6 Months after Covid-19 mRNA-1273 Vaccination in Patients with Chronic Kidney Disease, on Dialysis, or Living with a Kidney TransplantSemantic proximity Read

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on hemodialysisSemantic proximity Read

Immunogenicity of COVID-19 mRNA Vaccines in Immunocompromised Patients: A Systematic Review and Meta-AnalysisSemantic proximity Read

Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective studySemantic proximity Read

Humoral and Cellular Immunogenicity and Safety of 3 Doses of CoronaVac and BNT162b2 in Young Children and Adolescents with Kidney DiseasesSemantic proximity Read

Justification, safety, and efficacy of a third dose of mRNA vaccine in maintenance hemodialysis patients: a prospective observational studySemantic proximity Read

Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patientsSemantic proximity Read

Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: cohort studySemantic proximity Read

Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort studySemantic proximity Read

Safety and Effectiveness of COVID-19 Vaccines in Patients with IgA Nephropathy: A Retrospective Cohort Study from the TriNetX Global Collaborative NetworksSemantic proximity Read